Literature DB >> 11353109

Neurofibromatosis type 1: a diagnostic mimicker at CT.

B J Fortman1, B S Kuszyk, B A Urban, E K Fishman.   

Abstract

Neurofibromatosis type 1 (NF1) is the most common of the phakomatoses and has a variety of localized or, more frequently, systemic manifestations throughout the thorax, abdomen, pelvis, and extremities. Classic computed tomographic (CT) findings in NF1 with thoracic involvement include small, well-defined subcutaneous neurofibromas, focal thoracic scoliosis, posterior vertebral scalloping, enlarged neural foramina, and characteristic rib abnormalities due to bone dysplasia or erosion from adjacent neurofibromas. However, more atypical manifestations are occasionally seen, and magnetic resonance (MR) imaging can be useful in equivocal cases. NF1 with abdominopelvic involvement tends to arise in the retroperitoneal, mesenteric, and paraspinal regions; it may be quite extensive and therefore difficult to distinguish from adenopathy at CT. The multiplanar capabilities of MR imaging, particularly with T2 weighting, make this modality helpful in evaluating affected patients and making the diagnosis. The classic peripheral manifestations of NF1 include limb hemihypertrophy, pseudarthrosis, peripheral nerve neurofibromas, and subcutaneous common and plexiform neurofibromas. In some cases of NF1, imaging findings are inconclusive, and biopsy and subsequent pathologic analysis are required. Familiarity with the various manifestations of NF1 in different anatomic locations is important in making the diagnosis and optimizing postdiagnostic treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11353109     DOI: 10.1148/radiographics.21.3.g01ma05601

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  21 in total

1.  Giant plexiform neurofibroma with hemorrhage in cranio-maxillofacial region as depicted on CT and MRI.

Authors:  Y Feng; Zhi-Gang Yang; T Chen; Q Wang; W Deng
Journal:  Eur J Med Res       Date:  2010-02-26       Impact factor: 2.175

Review 2.  Imaging findings of diseases affecting the gastrohepatic ligament: not as acquiscent as it seems.

Authors:  Ali Devrim Karaosmanoglu; Omer Onder; Deniz Akata; Mustafa Nasuh Ozmen; Musturay Karcaaltincaba
Journal:  Abdom Radiol (NY)       Date:  2021-05-11

3.  Malignant transformation in a sciatic plexiform neurofibroma in Neurofibromatosis Type 1 - imaging features that aid diagnosis.

Authors:  Dorinda Chee Yee Chew; Daniel Bin Hang Zhao; Kesavan Sittampalam; S Krishna Kumar
Journal:  J Radiol Case Rep       Date:  2020-12-31

4.  Rib head dislocation causing spinal canal stenosis in a child with neurofibromatosis, type 1.

Authors:  Alan M Chen; Jeffrey B Neustadt; Jennifer Neville Kucera
Journal:  J Radiol Case Rep       Date:  2017-08-31

Review 5.  Imaging spectrum of mesenteric masses.

Authors:  Radwan Diab; Mayur Virarkar; Mohammed Saleh; Sherif Elsheif; Sanaz Javadi; Priya Bhosale; Silvana Faria
Journal:  Abdom Radiol (NY)       Date:  2020-11

6.  Endovascular treatment of basilar artery stenosis due to cerebral vasculopathy related to neurofibromatosis (NF1).

Authors:  Anand Alurkar; Lakshmi Sudha Prasanna Karanam; Sagar Oak
Journal:  J Vasc Interv Neurol       Date:  2014-05

7.  Lumbosacral plexiform neurofibroma: a rare case in an adult without neurofibromatosis type I.

Authors:  Naomi K Atkins; J Derek Stensby; Ayman H Gaballah
Journal:  Skeletal Radiol       Date:  2019-07-24       Impact factor: 2.199

Review 8.  Diagnostic imaging of benign and malignant neck masses in children-a pictorial review.

Authors:  Ruth Elizabeth Brown; Srikrishna Harave
Journal:  Quant Imaging Med Surg       Date:  2016-10

Review 9.  Adrenal and extra-adrenal myelolipomas - a comparative case report.

Authors:  Arsany Hakim; Christoph Rozeik
Journal:  J Radiol Case Rep       Date:  2014-01-01

10.  Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI.

Authors:  Akihiko Matsumine; K Kusuzaki; T Nakamura; S Nakazora; R Niimi; T Matsubara; K Uchida; T Murata; I Kudawara; T Ueda; N Naka; N Araki; M Maeda; A Uchida
Journal:  J Cancer Res Clin Oncol       Date:  2008-12-20       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.